Plasma pTau181 predicts Alzheimer’s progression in real-world memory clinic patients

Researchers confirm plasma pTau181 is a strong predictor for Alzheimer’s in patients with mild cognitive impairment, offering a less invasive diagnostic tool for early intervention.

Fianlimab by Regeneron Pharmaceuticals for Hematological Tumor: Likelihood of Approval

GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Attributes

June 18, 2024

Innovative approaches in polymer nanoparticle synthesis for RNA therapeutics

RNA therapy with polymer nanoparticles is considered a promising approach for the treatment of various illnesses.

July 15, 2024

Midi Health Raises $25M for Virtual Menopause Care Clinic – FemTech

Dr. Mindy Goldman (Chief Clinical Officer, Midi Health), Cindy Gentry, Sharon Meers (Co-Founder, Midi Health), Dr. Kathleen Jordan (Chief Medical Officer, Midi Health), Frédérique Dame

September 28, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.